NCT06178783

A Study of the Palatability and Acceptability of Different Brensocatib Oral Liquid Formulations in Healthy Participants

A Phase 1, Double-blind, Randomized, Single-center Study to Assess the Palatability and Acceptability of Different Brensocatib Oral Liquid Formulations in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Insmed Incorporated · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The primary purpose of this study is to assess the palatability and compare acceptability of brensocatib oral solutions.

Conditions

• Healthy Volunteers

Interventions

Type	Name	Description
DRUG	Brensocatib	Brensocatib oral solutions will be expectorated following the tasting.

Timeline

• Start date: 2023-12-27
• Primary completion: 2024-01-04
• Completion: 2024-01-04
• First posted: 2023-12-21
• Last updated: 2024-01-22

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study